🇺🇸 FDA
Patent

US 7659361

Maleamic acid polymer derivatives and their bioconjugates

granted A61KA61K47/60A61P

Quick answer

US patent 7659361 (Maleamic acid polymer derivatives and their bioconjugates) held by Nektar Therapeutics expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K47/60, A61P, A61P11/00, A61P25/00